ABSTRACT
Importance Population-wide facial masking decreases COVID-19 transmission but may also decrease the severity of disease by reducing the viral inoculum to which the wearer is exposed. The mortality of COVID-19 infection decreased in the U.S. in the second wave over the summer of 2020 compared to the first, but reasons for declining severity of disease have not been fully elucidated.
Objective To determine if facial mask mandates instituted in U.S. counties over the spring and summer of 2020 were associated with declining severity of infection as measured by the number of hospitalizations for COVID-19.
Design Data on hospitalizations due to COVID-19; testing access determined by number of tests performed per day per 100,000 people; new cases per day normalized by population; measures of population mobility to control for other non-pharmaceutical interventions such as lockdowns, social distancing, and business closures; age categories in each census tract; and dates of masking mandates in U.S. counties were all obtained from open-sourced epidemiologic datasets. We used a staggered difference-in-difference study design to assess the impact of the introduction of mask mandates (defined as the treatment) on the proportion of hospitalizations due to COVID-19 per week from March 10-September 16, 2020.
Setting U.S. counties with available full datasets on relevant COVID-19 metrics
Exposure Mask mandates
Main outcome Proportion of hospitalizations due to COVID-19
Results Using data from 1083 counties (34% of U.S. counties, 82% of U.S. population) from 49 states, we found a statistically significant drop in hospitalization rates due to COVID-19 up to 12 weeks following county mask mandates of 7.13 (95% CI: -4.19, -10.1) percentage points, after controlling for age categories by county, testing access, numbers of cases, and population mobility.
Conclusion and Relevance Facial masking may decrease COVID-19 severity by decreasing the viral inoculum to which individuals are exposed. Mask mandates across 1083 counties in the U.S. in 49 states decreased hospitalization rates from COVID-19 even when controlling for other factors that could impact disease severity, including age, testing access, number of cases, and mobility (as a proxy for other non-Pharmaceutical interventions such as sheltering-in-place). This study adds to the growing evidence for the impact of masking on disease severity and on the utility of population-wide facial masking for COVID-19 pandemic control.
Question Are mask mandates with an increase in population-wide facial masking in the U.S. associated with decreased hospitalizations due to COVID-19?
Findings We hypothesize that facial masking, by reducing the viral inoculum to which the wearer is exposed, can lead to less severe disease if infection occurs. Using publicly-sourced epidemiological data, we assessed the change in proportion of hospitalizations due to COVID-19 as a result of the introduction mask mandates in 1083 counties across 49 states in the U.S. (representing 82% of the U.S. population). We found a statistically significant drop of up to 7.13 (95% CI: -4.19, -10.1) percentage points in COVID-19 hospitalizations following mask mandates, while controlling for age categories in the county, testing and cases normalized by population, and population mobility (as a way to control for other non-pharmaceutical interventions such as sheltering-in-place).
Meaning Facial mask mandates seem to be associated with reduced severity of COVID-19 disease across the U.S.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Grant: NIAID/NIH R01AI158013 - Monica Gandhi
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exemption: de-identified publicly available data
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interests: The authors have no financial conflicts of interest to report
Data Availability
Publicly available de-identified data was obtained from the Delphi COVID-19 Surveillance Project dataset, open-sourced COVID-19 Tracking Project and SafeGraph COVID-19 Data Consortium
https://www.census.gov/programs-surveys/popest/technical-documentation/file-layouts.html
https://cmu-delphi.github.io/delphi-epidata/api/covidcast.html
https://covidtracking.com/about
https://www.safegraph.com/covid-19-data-consortium
https://bfi.uchicago.edu/working-paper/tracking-mask-mandates-during-the-covid-19-pandemic
